If you've mostly invested in things like stocks, ETFs, or mutual funds, the world of private equity might sound mysterious or out of reach. But it doesn’t have to be. In this post, we’ll break down what private equities are, why they’ve historically been reserved for a select few, and how Caduceus is changing that — especially for doctors who want to invest in what they understand.
Private Equity, Simply Explained
At its core, private equity (PE) means owning a piece of a company that isn’t listed on the public stock market. Instead of buying shares of Apple or Google through your brokerage account, you’re investing in a private business — often one that’s in its early or growth stage — before it ever goes public (if it does at all).
This could be a medical device startup, a biotech firm, or a health-tech company developing breakthrough software. You’re getting in at a stage where the company needs capital to grow — and where your investment could multiply in value over time.
How Do People Usually Get Private Equity?
Historically, private equity has been the playground of large institutional investors — like pension funds, endowments, and ultra-high-net-worth individuals. They gain access through venture capital firms or private equity funds with minimum investments often starting at $250,000 or more.
In addition to the high financial barrier, these deals have typically required inside connections. Founders raising money often turn to known networks of wealthy investors or specialized funds. That means most people — even physicians with solid incomes — were left out.
Why Are Private Equities Attractive?
The appeal is simple: upside potential.
When you invest early in a company — before it’s publicly traded — your dollar can go a lot further if that business succeeds. Think of the doctors who got into Moderna or 23andMe before those names hit the headlines. Returns in private equity can range from modest multiples to 10x or more, depending on the timing, industry, and execution.
Of course, it’s also higher risk. Many early-stage companies fail or take years to exit. That’s why private equity isn’t about chasing a quick win — it’s about strategic, long-term investing.
How Caduceus Makes Private Equity Accessible
At Caduceus, we’re opening this world to physicians like you.
We believe doctors have something incredibly valuable: domain knowledge. You know when a medical product makes sense. You understand when a clinical innovation could improve care. So instead of handing your capital over to someone else to decide what’s worth investing in — you participate directly.
Here’s how it works:
-
You join Caduceus as a Network Partner
-
You get access to curated startup presentations
-
You evaluate them through your own clinical and scientific lens
-
If you want to invest, you become an LP (Limited Partner) for that deal
We aggregate doctors into investment “pools” so that early-stage companies get the funding they need — and you get a seat at the table.
And because we structure these deals under private placement exemptions, we keep minimums low and access direct, while still maintaining SEC compliance (which is why accredited investor status is required).